直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Securing $240 million and a jury verdict of willful infringement for Promptu in patent case against Comcast

Promptu Systems Corporation

US Synthetic secures ITC exclusion order barring polycrystalline diamond compacts (PDCs)

US Synthetic Corporation

Achieving precedent in preserving valuable patents for Lumify®

Eye Therapies, LLC

Finnegan client Maglula delivers crushing blow to Amazon’s arbitration practices over counterfeit products

Maglula, Ltd.

Finnegan secures $180M for CSRC in complex arbitrations

CSRC et al.

Protecting a blockbuster diabetes treatment for AstraZeneca

AstraZeneca AB

Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini

Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.

Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement

Eisai Co., Ltd.

Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million

Intellia Therapeutics, Inc.

Recent Experience

Experience

Nanosys, Inc. v. The Board of Trustees of the University of Arkansas et al. Nanosys, Inc. v. The Board of Trustees of the University of Arkansas et al.

IPR2020-00503, PTAB, Judges Abraham, Guest, Heaney

Experience

Forward Pharma IP APS v. Biogen MA, Inc.  Forward Pharma IP APS v. Biogen MA, Inc. 

106,023, PTAB, Judges Gardner-Lane, Katz, Schafer

Experience

Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al. Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.

IPR2018-01403, PTAB, Judges Chagnon, Harlow, Snedden

Experience

Biogen International GmbH v. Teva Pharmaceuticals USA, Inc. Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.

1:17-cv-00829, D. Del., Judge Noreika
1:17-cv-00116, N.D.W. Va., Judge Keeley

Experience

Lo v. Quake Lo v. Quake

105,920; 105,923; 105,924, PTAB, Judges Gardner-Lane, Katz, Moore

Experience

PTAB denies institution of Coalition for Affordable Drugs inter partes review challenges to Biogen patents PTAB denies institution of Coalition for Affordable Drugs inter partes review challenges to Biogen patents

IPR2015-01086, -01136, -01993, PTAB, Judges Gardener-Lane, Katz, Schafer

Experience

Complete victory for Finnegan clients Nutrichem and Heyi at the ITC Complete victory for Finnegan clients Nutrichem and Heyi at the ITC

337-TA-914, ITC, Judge Lord

Experience

Voglewede v. Lee Voglewede v. Lee

Int. No. 105711, BPAI, Judge Lee

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP